PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29680917-3	2018	The results showed that production of TNF-alpha, IL-1beta, IL-6, and NO and TNF-alpha, IL-1beta, IL-6, and iNOS mRNA were inhibited by scutellarin, which was independent of cytotoxicity as assessed by a CCK8 assay.	scutellarin	135-146	interleukin 6	Mus musculus	59-63	
29680917-3	2018	The results showed that production of TNF-alpha, IL-1beta, IL-6, and NO and TNF-alpha, IL-1beta, IL-6, and iNOS mRNA were inhibited by scutellarin, which was independent of cytotoxicity as assessed by a CCK8 assay.	scutellarin	135-146	interleukin 6	Mus musculus	97-101	
34624394-5	2021	In addition, scutellarin inhibited LPS-induced elevation of TNFalpha, IL-1beta, IL-6 and iNOS, and reversed the downregulation of IL-4 and BDNF in astrocytes in vitro.	scutellarin	13-24	interleukin 6	Mus musculus	80-84	
34118224-4	2021	Besides, Scutellarin attenuated mouse serum concentrations of TNF-alpha and IL-6, heightened Bax expression and diminished B-cell lymphoma-2 (Bcl-2) level in CAC tissues of mice, through down-regulating Wnt/beta-catenin signaling cascade.	scutellarin	9-20	interleukin 6	Mus musculus	76-80	
28849116-8	2017	The present study demonstrated that scutellarin prevented CIA, and inhibited the expression of inflammation factors, IL-1beta, IL-6 and TNF-alpha.	scutellarin	36-47	interleukin 6	Mus musculus	127-131	
29642616-5	2018	After nine months of treatment in APP/PS1 double-transgenic mice, scutellarin significantly improves behavior, reduces soluble and insoluble Abeta levels in the brain and plasma, decreases Abeta plaque associated gliosis and levels of proinflammatory cytokines TNF-alpha and IL-6, attenuates neuroinflammation, displays anti-amyloidogenic effects, and highlights the beneficial effects of intervention on development or progression of AD-like neuropathology.	scutellarin	66-77	interleukin 6	Mus musculus	275-279